Evaluation of α-synuclein and apolipoprotein E as potential biomarkers in cerebrospinal fluid to monitor pharmacotherapeutic efficacy in dopamine dictated disease states of Parkinson’s disease and schizophrenia

Código QR

Evaluation of α-synuclein and apolipoprotein E as potential biomarkers in cerebrospinal fluid to monitor pharmacotherapeutic efficacy in dopamine dictated disease states of Parkinson’s disease and schizophrenia

Ashish Kumar Gupta,1 Ruchika Pokhriyal,1 Uddipan Das,1 Mohd Imran Khan,1 Domada Ratna Kumar,1 Rishab Gupta,2 Rakesh Kumar Chadda,2 Rashmi Ramachandran,3 Vinay Goyal,4 Manjari Tripathi,4 Gururao Hariprasad11Department of Biophysics; 2Department of Psychiatry; 3Department of Anaesthesia; 4Department o...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Gupta AK, Pokhriyal R, Das U, Khan MI, Ratna Kumar D, Gupta R, Chadda RK, Ramachandran R, Goyal V, Tripathi M, Hariprasad G
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2019
Materias:	Cerebro-spinal fluid Parkinson’s disease schizophrenia dopamine apolipoprotein E α-synuclein biomarkers treatment monitoring Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/6dfb296e043f45569a1b43ba43fee3c2
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Cerebrospinal Fluid Proteomics For Identification Of α2-Macroglobulin As A Potential Biomarker To Monitor Pharmacological Therapeutic Efficacy In Dopamine Dictated Disease States Of Parkinson’s Disease And Schizophrenia
por: Gupta AK, et al.
Publicado: (2019)

2D-DIGE as a strategy to identify serum protein biomarkers to monitor pharmacological efficacy in dopamine-dictated states of Parkinson’s disease and schizophrenia
por: Gupta AK, et al.
Publicado: (2019)

The Retinal Posterior Pole in Early Parkinson’s Disease: A Fundus Perimetry and SD-OCT Study
por: Cesareo M, et al.
Publicado: (2021)

The Small Molecule Alpha-Synuclein Aggregator, FN075, Enhances Alpha-Synuclein Pathology in Subclinical AAV Rat Models
por: Rachel Kelly, et al.
Publicado: (2021)

Alpha-Synuclein and Cognitive Decline in Parkinson Disease
por: Tian-Sin Fan, et al.
Publicado: (2021)

CK1BP Reduces α-Synuclein Oligomerization and Aggregation Independent of Serine 129 Phosphorylation
por: Lea Elsholz, et al.
Publicado: (2021)

Polymorphism of apolipoprotein A1 gene and lipid profile of blood serum in the Evenki and Buryat populations
por: S. I. Kolesnikov, et al.
Publicado: (2015)

Apolipoprotein-b gen and its role in formation of essential hypertension
por: L. I. Kolesnikova, et al.
Publicado: (2015)

Apolipoprotein B gene mutation related to familial hypercholesterolemia in an Iranian population: With or without hypothyroidism
por: Golnaz Vaseghi, et al.
Publicado: (2021)

Alpha-Synuclein Induced Immune Cells Activation and Associated Therapy in Parkinson’s Disease
por: Ruichen Su, et al.
Publicado: (2021)

Apolipoprotein A5-1131T>C Polymorphism Associated with Lipid Profile in Babol Population
por: SH Shojaee, et al.
Publicado: (2010)

Apolipoprotein B/A1 ratio as a potential marker of cardiovascular risk in women
por: Olufisayo Gabriel Ayoade, et al.
Publicado: (2021)

High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson’s disease
por: Marco J. Russo, et al.
Publicado: (2021)

Apolipoprotein E e4 allele is associated with extrapyramidal symptoms in Alzheimer’s disease
por: Chang YP, et al.
Publicado: (2019)

ABBV-0805, a novel antibody selective for soluble aggregated α-synuclein, prolongs lifespan and prevents buildup of α-synuclein pathology in mouse models of Parkinson's disease
por: Eva Nordström, et al.
Publicado: (2021)

Concentración sérica de apolipoproteínas A-I y B en niños y adolescentes
por: Casanueva E,Victor, et al.
Publicado: (1995)

Phosphorylation of Tau and α-Synuclein Induced Neurodegeneration in MPTP Mouse Model of Parkinson’s Disease
por: Hu S, et al.
Publicado: (2020)

SERUM MYELOPEROXIDASE, MALONDIALDEHYDE, ALPHA-SYNUCLEIN LEVELS IN PATIENTS WITH EPILEPSY
por: Fatma Şimşek, et al.
Publicado: (2021)

Study of apolipoprotein C3 S1/S2 (C3238G, rs5128) polymorphism in Caucasian population of Eastern Siberia
por: O. V. Kalyuzhnaya, et al.
Publicado: (2014)

Association between apolipoprotein E gene polymorphism and mild cognitive impairment: a meta-analysis
por: Jiang Y, et al.
Publicado: (2017)

Association of serum 25-Hydroxy Vitamin D level with lipid, lipoprotein, and apolipoprotein level
por: Cyrus Elmi, et al.
Publicado: (2021)

Detection of hyperphosphorylated tau protein and α-synuclein in spinal cord of patients with Alzheimer’s disease
por: Guo YJ, et al.
Publicado: (2016)

Assembly of α-synuclein and neurodegeneration in the central nervous system of heterozygous M83 mice following the peripheral administration of α-synuclein seeds
por: Jennifer A. Macdonald, et al.
Publicado: (2021)

Apolipoprotein ε7 allele in memory complaints: insights through protein structure prediction
por: Youn YC, et al.
Publicado: (2017)

Association of Apolipoprotein E Gene Polymorphism with Ischemic Stroke in Coronary Heart Disease Patients Treated with Medium-intensity Statins
por: Lv P, et al.
Publicado: (2020)

The effect of the addition of resistance training to a dietary education intervention on apolipoproteins and diet quality in overweight and obese older adults
por: Valente EA, et al.
Publicado: (2011)

Association of leisure-time physical activity with cognition by apolipoprotein-E genotype in persons aged 60 years and over: the National Health and Nutrition Examination Survey (NHANES-III)
por: Obisesan TO, et al.
Publicado: (2012)

α-synuclein interaction with zero-valent iron nanoparticles accelerates structural rearrangement into amyloid-susceptible structure with increased cytotoxic tendency
por: Tahaei Gilan SS, et al.
Publicado: (2019)

ERRORES NEURORRADIOLOGICOS FRECUENTES EN TC Y RM
por: Orellana P.,Patricia
Publicado: (2003)

Apolipoprotein E3-mediated cellular uptake of reconstituted high-density lipoprotein bearing core 3, 10, or 17 nm hydrophobic gold nanoparticles
por: Chuang ST, et al.
Publicado: (2017)

Lentiviral Vectors Expressing Chimeric NEDD4 Ubiquitin Ligases: An Innovative Approach for Interfering with Alpha-Synuclein Accumulation
por: Stefania Vogiatzis, et al.
Publicado: (2021)

Effect of superparamagnetic nanoparticles coated with various electric charges on α-synuclein and β-amyloid proteins fibrillation process
por: Javdani N, et al.
Publicado: (2019)

Examining the Toxicity of α-Synuclein in Neurodegenerative Disorders
por: Frank Y. Shan, et al.
Publicado: (2021)

Polymorphism of Alpha-Synuclein Amyloid Fibrils Depends on Ionic Strength and Protein Concentration
por: Mantas Ziaunys, et al.
Publicado: (2021)

Sgt1 Regulates α-Synuclein Subcellular Localization and Expression of Parkinson’s Disease Related Genes, <i>PINK1</i> and <i>PARK9</i>
por: Anastasiia Bohush, et al.
Publicado: (2021)

Tinnitus: Una patología cerebral
por: Wimmer del S,Jonathan, et al.
Publicado: (2019)

La Dislexia del Desarrollo: Gen, Cerebro y Cognición
por: Galaburda,Alberto M, et al.
Publicado: (2006)

Inhibition of LRRK2 kinase activity promotes anterograde axonal transport and presynaptic targeting of α-synuclein
por: Charlotte F. Brzozowski, et al.
Publicado: (2021)

Commentary: Dopamine-Dependent Early Synaptic and Motor Dysfunctions Induced by α-Synuclein in the Nigrostriatal Circuit
por: Jiahui Zhang, et al.
Publicado: (2021)

LRRK2 inhibitors and their potential in the treatment of Parkinson’s disease: current perspectives
por: Atashrazm F, et al.
Publicado: (2016)